J.H.M. Schellens

675 total citations
15 papers, 528 citations indexed

About

J.H.M. Schellens is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J.H.M. Schellens has authored 15 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J.H.M. Schellens's work include Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers) and Neutropenia and Cancer Infections (3 papers). J.H.M. Schellens is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers) and Neutropenia and Cancer Infections (3 papers). J.H.M. Schellens collaborates with scholars based in Netherlands, United Kingdom and United States. J.H.M. Schellens's co-authors include Hilde Rosing, Jos H. Beijnen, Olaf van Tellingen, J. H. Beijnen, W W ten Bokkel Huinink, Kenneth R. Brouwer, Heleen A. Bardelmeijer, W J Nooijen, Johann S. de Bono and Peter C.C. Fong and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and British journal of surgery.

In The Last Decade

J.H.M. Schellens

15 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.H.M. Schellens Netherlands	10	378	141	118	86	68	15	528
Femke M. de Man Netherlands	10	245 0.6×	219 1.6×	48 0.4×	47 0.5×	24 0.4×	19	539
Jos H. Beijnen Netherlands	6	358 0.9×	114 0.8×	196 1.7×	92 1.1×	13 0.2×	9	489
Krisztina Herédi‐Szabó Hungary	15	457 1.2×	142 1.0×	221 1.9×	179 2.1×	13 0.2×	21	644
Shun‐ichi Ikeda Japan	14	273 0.7×	241 1.7×	84 0.7×	24 0.3×	127 1.9×	55	816
C.M.F. Kruijtzer Netherlands	8	565 1.5×	210 1.5×	223 1.9×	123 1.4×	8 0.1×	9	710
Elaine Paul United States	13	950 2.5×	363 2.6×	272 2.3×	124 1.4×	16 0.2×	22	1.1k
Isabelle Lochon France	13	326 0.9×	248 1.8×	25 0.2×	51 0.6×	43 0.6×	22	574
Varun Garg United States	11	174 0.5×	94 0.7×	50 0.4×	47 0.5×	14 0.2×	18	397
Belén Valenzuela Spain	14	189 0.5×	133 0.9×	21 0.2×	24 0.3×	22 0.3×	43	440
Sikic Bi United States	10	282 0.7×	276 2.0×	36 0.3×	25 0.3×	24 0.4×	13	547

Countries citing papers authored by J.H.M. Schellens

Since Specialization

Citations

This map shows the geographic impact of J.H.M. Schellens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.H.M. Schellens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.H.M. Schellens more than expected).

Fields of papers citing papers by J.H.M. Schellens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.H.M. Schellens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.H.M. Schellens. The network helps show where J.H.M. Schellens may publish in the future.

Co-authorship network of co-authors of J.H.M. Schellens

This figure shows the co-authorship network connecting the top 25 collaborators of J.H.M. Schellens. A scholar is included among the top collaborators of J.H.M. Schellens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.H.M. Schellens. J.H.M. Schellens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kaaij, Rosa T. van der, Emma C. E. Wassenaar, Willem J. Koemans, et al.. (2020). Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results. British journal of surgery. 107(11). 1520–1528. 35 indexed citations

Rosing, Hilde, Matthijs M. Tibben, Rubin Lubomirov, et al.. (2018). Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of 14C-plitidepsin. Cancer Chemotherapy and Pharmacology. 82(3). 441–455. 4 indexed citations

Thijssen, Bram, M. J. X. Hillebrand, Hilde Rosing, et al.. (2017). Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of Dexamphetamine in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 148. 259–264. 3 indexed citations

Nijenhuis, Cynthia M., Hilde Rosing, Alwin D. R. Huitema, et al.. (2017). Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II. Investigational New Drugs. 35(4). 478–490. 3 indexed citations

Nuland, Merel van, M. J. X. Hillebrand, Hilde Rosing, et al.. (2017). Ultra-sensitive LC–MS/MS method for the quantification of gemcitabine and its metabolite 2′,2′-difluorodeoxyuridine in human plasma for a microdose clinical trial. Journal of Pharmaceutical and Biomedical Analysis. 151. 25–31. 16 indexed citations

Nijenhuis, Cynthia M., Hilde Rosing, Gene C. Jamieson, et al.. (2016). Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 1027. 1–10. 3 indexed citations

Kip, Anke E, Hilde Rosing, M. J. X. Hillebrand, et al.. (2016). Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection. Antimicrobial Agents and Chemotherapy. 60(4). 2081–2089. 16 indexed citations

Goey, Andrew K.L., Jos H. Beijnen, & J.H.M. Schellens. (2014). Herb–Drug Interactions in Oncology. Clinical Pharmacology & Therapeutics. 95(4). 354–355. 18 indexed citations

Fong, Peter C.C., David S. Boss, C. P. Carden, et al.. (2008). AZD2281 (KU-0059436), a PARP (poly ADP-ribose polymerase) inhibitor with single agent anticancer activity in patients with BRCA deficient ovarian cancer: Results from a phase I study. Journal of Clinical Oncology. 26(15_suppl). 5510–5510. 65 indexed citations

10.

Yap, Timothy A., David S. Boss, Peter C.C. Fong, et al.. (2007). First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriers. Journal of Clinical Oncology. 25(18_suppl). 3529–3529. 49 indexed citations

11.

Fong, Peter C.C., James Spicer, Alex Reid, et al.. (2006). Phase I pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of a small molecule inhibitor of Poly ADP-Ribose Polymerase (PARP), KU-0059436 (Ku) in patients (p) with advanced tumours. Journal of Clinical Oncology. 24(18_suppl). 3022–3022. 29 indexed citations

12.

Joerger, Markus, J.H.M. Schellens, & Jos H. Beijnen. (2004). Therapeutic drug monitoring of non-anticancer drugs in cancerpatients. Methods and Findings in Experimental and Clinical Pharmacology. 26(7). 531–531. 20 indexed citations

13.

Veenhuizen, Ruth B., Marjan Ruevekamp, Hugo Oppelaar, et al.. (2001). <title>Optimization of photodynamic therapy: the influence of photosensitizer uptake and distribution on tumor response</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4156. 63–68. 1 indexed citations

14.

Bardelmeijer, Heleen A., Jos H. Beijnen, Kenneth R. Brouwer, et al.. (2000). Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.. PubMed. 6(11). 4416–21. 103 indexed citations

15.

Beijnen, J. H., et al.. (1999). Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.. PubMed. 5(11). 3379–84. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact